VCV000545584.2 - ClinVar

CYP2C8*3

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(1)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Benign

no assertion criteria provided

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

This haplotype includes the following variants

CYP2C8*3

Other names: -
Functional consequence: -
Links: OMIM: 601129.0002

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
CYP2C8		-	-	GRCh38 GRCh37	48	80

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
CYP2C8 HAPLOTYPE POLYMORPHISM	Benign (1)	no assertion criteria provided	Jun 20, 2018	RCV000656544.10

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Benign (Jun 20, 2018)	no assertion criteria provided Method: literature only	CYP2C8 HAPLOTYPE POLYMORPHISM Affected status: not provided Allele origin: germline	OMIM Accession: SCV000778563.1 First in ClinVar: Jun 23, 2018 Last updated: Jun 23, 2018	Publications: PubMed (2) PubMed: 26721703‚ 28378927 Comment on evidence: The CYP2C83 polymorphism is comprised of 2 in cis variants: a c.416G-A transition (c.416G-A, NM_000770.3) in exon 3, resulting in an arg139-to-lys (R139K) substitution, and … (more) The CYP2C83 polymorphism is comprised of 2 in cis variants: a c.416G-A transition (c.416G-A, NM_000770.3) in exon 3, resulting in an arg139-to-lys (R139K) substitution, and a c.1196A-G transition (c.1196A-G, NM_00770.3) in exon 8, resulting in a lys339-to-arg (K339R) substitution, that are in complete or nearly complete linkage (summary by Backman et al., 2016). Zhou et al. (2017) found the highest allele frequency of CYP2C8*3 (11%) in individuals of European ancestry. The allele frequency in admixed American, South Asian, and African populations was about 7%, 4%, and 2%, respectively. In East Asians, the allele frequency was less than 0.1%. (less)

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Citations for germline classification of this variant

Title	Author	Journal	Year	Link
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.	Zhou Y	Clinical pharmacology and therapeutics	2017	PMID: 28378927
Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions.	Backman JT	Pharmacological reviews	2016	PMID: 26721703

Text-mined citations for this variant ...

Record last updated Nov 19, 2024

ClinVar Genomic variation as it relates to human health

CYP2C8*3

Variant Details

CYP2C8*3

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...